Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a guided Self-Care plan tame atrial Fibrillation's return?

NCT ID NCT07741682

Symptom relief Sponsor: Binzhou People's Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This trial tests whether a structured self-management program, based on the Common-Sense Model of Self-Regulation, can help people recover after a procedure to treat atrial fibrillation (an irregular heartbeat). Participants will be randomly assigned to receive either routine nursing care or the extra self-management support, which includes guidance on managing their condition and recognizing risks. The study will track self-management skills, recurrence of atrial fibrillation, coping strategies, and social support over a year to see if the program makes a meaningful difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A structured self-management nursing program based on the Common-Sense Model of Self-Regulation, added to routine care
What this could lead to
If effective, this program could become a standard part of recovery care for people after atrial fibrillation ablation, helping them manage their health better and potentially reducing the chance of the heart rhythm problem returning.
What could go wrong
This is a relatively small, single-center trial, so results may not apply to all patients. The program's success depends on patient engagement, and it may not significantly change recurrence rates or long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

88 people

The number who actually took part.

Started

Oct 2024

Finished

Nov 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients diagnosed with atrial fibrillation based on electrophysiological testing； * Planned radio frequency ablation procedure； * Patients whose condition is stable, who have impaired consciousness, and who are able to communicate without difficulty； * Patients who know how to use a smartphone and WeChat, or whose family members are willing to help them use these apps； * Voluntarily participate in this study and sign the informed consent form. Exclusion Criteria: * Combined severe heart, brain, lung, kidney, and other serious diseases； * Current or past history of mental illness, psychiatric disorders, or cognitive impairments； * Has participated in other studies.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Atrial fibrillation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Atrial fibrillation

Contacts and locations

Locations

  • The Affiliated Hospital of Qingdao University

    Qingdao, Shandong, 266000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.